DATA SHEET MALARONE TABLETS and …
1 DATA SHEET MALARONE® TABLETS and MALARONE® JUNIOR TABLETS Presentation MALARONE tablets are round, biconvex, pink film coated tablets, engraved on one side with “GX CM3”.
Download DATA SHEET MALARONE TABLETS and …
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Oral Dosage Forms That Should Not Be Crushed
www.consumermedsafety.orgPage 1 of 16 Oral Dosage Forms That Should Not Be Crushed John F. Mitchell, PharmD, FASHP1 Last updated: March 2012 Drug Product (active ingredient) 2 Dosage Form Reasons/Comments 3Accutane (ISOtretinoin) Capsule Mucous membrane irritant Aciphex (RABEprazole) Tablet Slow-release Actiq (fentaNYL) Lozenge Slow-release …
Dosage Form Design: Pharmaceutical and …
downloads.lww.comCHAPTER prescribe. The general area of study concerned with the formulation, manufacture, stability, and effectiveness of pharmaceutical dosage forms is
US-18970 HIGHLIGHTS OF PRESCRIBING …
www.azpicentral.comMOVANTIK® (naloxegol) tablets, for oral use 2.3 Dosage in Adult Patients with Renal Impairment The starting dosage for patients with creatinine clearance (CLcr) < 60 mL/min (i.e., patients with
REVISION OF MONOGRAPH ON TABLETS - World …
www.who.intDocument QAS/09.324/Final page 2 gastrointestinal tract, colouring matter authorised by the appropriate national or regional authority, and flavouring substances.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
docs.boehringer-ingelheim.com3 3 DOSAGE FORMS AND STRENGTHS 150 mg capsules: brown, opaque, oblong, soft capsules imprinted in black with the Boehringer Ingelheim company symbol and "150".
Oral Dosage Forms That Should Not Be Crushed …
www.mysccg.comReasons/Comments Absorica (isotretinoin) Capsule Mucous membrane irritant: Accutane (isotretinoin) Capsule: Mucous membrane irritant …
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET OxyNorm® Capsules & Oral Liquid (OXYNORM011) 29 June 2017 Page 3 of 14 Method of administration OXYNORM capsules should be swallowed whole and not opened, chewed or crushed.
VENCLEXTA (venetoclax tablets) for oral use or after ...
www.rxabbvie.comPatients should continue VENCLEXTA 400 mg once daily for 24 months from Cycle 1 Day 1 of rituximab. VENCLEXTA as Monotherapy The recommended dose of VENCLEXTA is 400 mg once daily after the patient has completed